Immunogen (IMGN) Misses Q1 EPS by 4c
Get Alerts IMGN Hot Sheet
Price: $31.25 --0%
Revenue Growth %: -100.0%
Financial Fact:
Total operating expenses: 46.5M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: -100.0%
Financial Fact:
Total operating expenses: 46.5M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q1 EPS of ($0.39), $0.04 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $15.84 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- S&P Global (SPGI) Tops Q1 EPS by 36c; offers guidance
- American Airlines (AAL) Misses Q1 EPS by 7c, Guidance Beats
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!